000 01307 a2200385 4500
005 20250513104948.0
264 0 _c19970305
008 199703s 0 0 eng d
022 _a0362-5664
024 7 _a10.1097/00002826-199619060-00003
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPantoni, L
245 0 0 _aA preliminary open trial with nimodipine in patients with cognitive impairment and leukoaraiosis.
_h[electronic resource]
260 _bClinical neuropharmacology
_cDec 1996
300 _a497-506 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aCerebrovascular Disorders
_xdrug therapy
650 0 4 _aCognition Disorders
_xdrug therapy
650 0 4 _aDementia, Vascular
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeuropsychological Tests
650 0 4 _aNimodipine
_xadverse effects
650 0 4 _aVasodilator Agents
_xadverse effects
700 1 _aCarosi, M
700 1 _aAmigoni, S
700 1 _aMascalchi, M
700 1 _aInzitari, D
773 0 _tClinical neuropharmacology
_gvol. 19
_gno. 6
_gp. 497-506
856 4 0 _uhttps://doi.org/10.1097/00002826-199619060-00003
_zAvailable from publisher's website
999 _c8930185
_d8930185